Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00996086 · ClinicalTrials.gov registry record
Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 154
- Enrollment target
NCT00996086 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 154 participants.
The verdict
NCT00996086 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 154 participants
- Enrollment target
Study Summary
This is an observational study to learn which patients benefit from CRT therapy and to track the clinical changes that help identify the risk-level of CRT patients.
Interventions
- DEVICE CRT device implant
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2010-02 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00996086
The ClinicalTrials.gov registry entry for NCT00996086 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CRT device implant is the first listed.
NCT00996086 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00996086 about?
NCT00996086 is a clinical study titled "Risk Stratification and Benefits With Cardiac Resynchronization Therapy (CRT)". This is an observational study to learn which patients benefit from CRT therapy and to track the clinical changes that help identify the risk-level of CRT patients.
What is the current status of trial NCT00996086?
This trial is currently completed. The enrollment target is 154 participants. The study started on 2010-02. Estimated completion is 2012-09.
What interventions are being tested in trial NCT00996086?
The interventions under investigation include: CRT device implant (DEVICE).
Who is sponsoring clinical trial NCT00996086?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.